Skip to content

The effect of nutrition in cardiac surgical patients on heart function.

The effect of perioperative (par)enteral nutrition on amino acid profile, cardiomyocytes functioning, and cardiac perfusion and metabolism of the cardiac surgical patient.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20597
Enrollment
48
Registered
2010-01-26
Start date
2010-04-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease, heart failure. Coronair lijden, hartfalen.

Interventions

Our patients will be given enteral nutrition (n=16), peripheral parenteral nutrition (n=16) or a saline solution (control) (n=16) at least three days before, during, and one day after CABG. Both enter

Sponsors

Academic Medical Center University of Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who have to undergo an off-pump coronary artery bypass grafting (CABG) operation; 2. Aged 18 till 81 years.

Exclusion criteria

Exclusion criteria: 1. Combined valve and CABG procedures; 2. Aged 80 years; 3. Diabetes mellitus type I; 4. Pregnancy; 5. Renal insufficiency defined as creatinine > 95 micromol/L for women and > 110 micromol/L for men; 6. Liver insufficiency defined as alanine aminotransferase > 34 U/I for women and > 45 U/I for men.

Design outcomes

Primary

MeasureTime frame
The main study outcomes are concentrations of amino acids, and methylated arginines in blood plasma and cardiac tissue, and cardiomyocytes functioning assessed by histology.

Secondary

MeasureTime frame
The secondary study outcomes are cardiac perfusion, and cardiac fatty acid and glucose metabolism, measured by myocardial scintigraphy and positron emission tomography.

Contacts

Public ContactB.A.J.M. Mol, de

P.O. Box 22700

b.a.demol@amc.uva.nl+31 (0)20 5666088

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)